- EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome
-
da Costa BHB, Becker AP, Neder L, Gonçalves PG, de Oliveira C, Polverini AD, Clara CA, Teixeira GR, Reis RM, Bidinotto LT
- KMID: 2531612
- J Pathol Transl Med.
- 2022 Jul;56(4):205-211.
- doi: 10.4132/jptm.2022.04.22
Background: Despite the advances in glioblastoma (GBM) treatment, the average life span of patients is 14 months. Therefore, it is urgent to identity biomarkers of prognosis, treatment response, or development... -
- CITED
-
- Close
- SHARE
-
- Close
